Page last updated: 2024-11-12

cobinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID91820010
CHEBI ID28956
CHEBI ID48529
CHEBI ID141013
MeSH IDM0067657

Synonyms (9)

Synonym
CHEBI:28956
cobinamid
cob(i)inamide
COBINAMIDE ,
cbi(i)
CHEBI:48529
cob(ii)inamide
CHEBI:141013
cbi(ii)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Hydrogen sulfide is a highly toxic gas-second only to carbon monoxide as a cause of inhalational deaths."( Hydrogen Sulfide--Mechanisms of Toxicity and Development of an Antidote.
Ali, S; Ambasudhan, R; Boss, GR; Brenner, M; Chan, A; Glasheen, M; Haushalter, KJ; Jiang, J; Lam, WL; Lipton, SA; Mahon, SB; Parker, J; Patel, HH; Pilz, RB; Saha, A, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
" We have shown that aquohydroxocobinamide is a potent cyanide antidote in animal models of cyanide poisoning, but it is unstable in solution and poorly absorbed after intramuscular injection."( Nitrocobinamide, a new cyanide antidote that can be administered by intramuscular injection.
Boss, GR; Brenner, M; Burney, T; Chan, A; Fridman, A; Green, C; Guo, LT; Haushalter, KJ; Jiang, J; Lee, J; Liu, MT; Mahon, SB; Mukai, D; Patel, HH; Pilz, RB; Shelton, GD; Yoon, D, 2015
)
0.42
" We found that potential interactions between the drug and the extracellular matrix (ECM) at the injection site can also affect the rate of absorption post-injection."( Decellularized skeletal muscle as an in vitro model for studying drug-extracellular matrix interactions.
Boss, GR; Christman, KL; Wassenaar, JW, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" Rapid administration of antidotes can result in complete resuscitation of the patient but judicious dosing requires the knowledge of the level of cyanide exposure."( A disposable blood cyanide sensor.
Boss, GR; Brenner, M; Dasgupta, PK; Ma, J; Mahon, SB; Tian, Y; Wang, JH, 2013
)
0.39
", large effective dosage or delayed onset of action)."( Simultaneous determination of 3-mercaptopyruvate and cobinamide in plasma by liquid chromatography-tandem mass spectrometry.
Boss, GR; Dzisam, JK; Logue, BA; Monteil, AR; Patterson, SE; Petrikovics, I; Rockwood, GA; Stutelberg, MW, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
adenosylcobalamin salvage from cobinamide I419

Research

Studies (112)

TimeframeStudies, This Drug (%)All Drugs %
pre-199031 (27.68)18.7374
1990's11 (9.82)18.2507
2000's20 (17.86)29.6817
2010's47 (41.96)24.3611
2020's3 (2.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.75%)6.00%
Case Studies1 (0.88%)4.05%
Observational0 (0.00%)0.25%
Other111 (97.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]